Skip navigation

Biogen Inc.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$11,449
Revenue Growth (%)6.36%
Net Income (US$ Millions)$3,703
Earnings Per Share (US$)$16.93
EPS Growth Rate (%)10.37%
Profit Margin32.34%
Total Equity (US$ Millions)$12,140
Return on Equity (%)39.51%
Long Term Debt (US$ Millions)$6,513
Debt To Equity Ratio (%)0.54%
Total Assets (US$ Millions)$22,877
Current Assets (US$ Millions)$8,732
Current Liabilities (US$ Millions)$3,420
Cost of Goods Sold (US$ Millions)$1,479
Inventory Turnover1.56